🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The pharmacokinetic (PK) profile of tralokinumab (CAT-354) will be studied ...
Status
Completed
Location
Research Site
Start Date
2012-06
Trial ID
NCT01592396
Treatments Being Tested
The aim of the study is to evaluate the efficacy and safety of tralokinumab...
Status
Completed
Location
Research Site
Start Date
2015-01-23
Trial ID
NCT02347176
Treatments Being Tested
The purpose of this trial is to investigate if tralokinumab changes the met...
Status
Completed
Location
LEO Pharma Investigational Site
Start Date
2018-08-13
Trial ID
NCT03556592
Treatments Being Tested
Primary objective: To evaluate the efficacy of subcutaneous (SC) administr...
Status
Completed
Location
LEO Pharma Investigational Site
Start Date
2018-06-19
Trial ID
NCT03526861
Treatments Being Tested
The purpose of this trial is to test if treatment with the trial drug, tral...
Status
Completed
Location
Leo Pharma Investigational Site
Start Date
2018-07-13
Trial ID
NCT03562377
Treatments Being Tested
Primary objective: To evaluate the efficacy of tralokinumab compared with ...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2017-05-30
Trial ID
NCT03131648
Treatments Being Tested
The primary objective of this study is to evaluate the pharmacokinetics (PK...
Status
Completed
Location
Celerion
Start Date
2014-03-19
Trial ID
NCT02085473
Treatments Being Tested
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495
The purpose of this study is to determine whether the addition of tralokinu...
Status
Completed
Location
Research Site
Start Date
2011-08
Trial ID
NCT01402986
Treatments Being Tested
A 52-Week, Multicentre, Randomized, Double-Blind, Parallel Group, Placebo C...
Status
Completed
Location
Research Site
Start Date
2014-06-13
Trial ID
NCT02161757
Treatments Being Tested